High-throughput amplicon-based copy number detection of 11 genes in formalin-fixed paraffin-embedded ovarian tumour samples by MLPA-seq

PLoS ONE

Volumn 10, Issue 11, 2015, Pages

  Kondrashova, Olga ^a   Love, Clare J ^a,b   Lunke, Sebastian ^a   Hsu, Arthur L ^a   Bowtell, D ^c   Chenevix Trench, G ^c   Green, A ^c   Webb, P ^c   DeFazio, A ^c   Gertig, D ^c   Traficante, N ^c   Fereday, S ^c   Moore, S ^c   Hung, J ^c   Harrap, K ^c   Sadkowsky, T ^c   Pandeya, N ^c   Malt, M ^c   Mellon, A ^c   Robertson, R ^c   Vanden Bergh, T ^c   Jones, M ^c   Mackenzie, P ^c   Maidens, J ^c   Nattress, K ^c   Chiew, Y E ^c   Stenlake, A ^c   Sullivan, H ^c   Alexander, B ^c   Ashover, P ^c   Brown, S ^c   Corrish, T ^c   Green, L ^c   Jackman, L ^c   Ferguson, K ^c   Martin, K ^c   Martyn, A ^c   Ranieri, B ^c   White, J ^c   Jayde, V ^c   Mamers, P ^c   Bowes, L ^c   Galletta, L ^c   Giles, D ^c   Hendley, J ^c   Alsop, K ^c   Schmidt, T ^c   Shirley, H ^c   Ball, C ^c   Young, C ^c   Viduka, S ^c   Tran, Hoa ^c   Bilic, Sanela ^c   Glavinas, Lydia ^c   Brooks, Julia ^c   Stuart Harris, R ^c   Kirsten, F ^c   Rutovitz, J ^c   Clingan, P ^c   Glasgow, A ^c   Proietto, A ^c   Braye, S ^c   Otton, G ^c   Shannon, J ^c   Bonaventura, T ^c   Stewart, J ^c   Begbie, S ^c   Friedlander, M ^c   Bell, D ^c   Baron Hay, S ^c   Ferrier, A ^c   Gard, G ^c   Nevell, D ^c   Pavlakis, N ^c   Valmadre, S ^c   Young, B ^c   Camaris, C ^c   Crouch, R ^c   Edwards, L ^c   Hacker, N ^c   Marsden, D ^c   Robertson, G ^c   Beale, P ^c   Beith, J ^c   Carter, J ^c   Dalrymple, C ^c   Houghton, R ^c   Russell, P ^c   Links, M ^c   Grygiel, J ^c   Hill, J ^c   Brand, A ^c   Byth, K ^c   Jaworski, R ^c   Harnett, P ^c   Sharma, R ^c   Wain, G ^c   Ward, B ^c   Papadimos, D ^c   Crandon, A ^c   Cummings, M ^c   Horwood, K ^c   Obermair, A ^c   Perrin, L ^c   Wyld, D ^c   Nicklin, J ^c   Davy, M ^c   Oehler, M K ^c   Hall, C ^c   Dodd, T ^c   Healy, T ^c   Pittman, K ^c   Henderson, D ^c   Miller, J ^c   Pierdes, J ^c   Blomfield, P ^c   Challis, D ^c   McIntosh, R ^c   Parker, A ^c   Brown, B ^c   Rome, R ^c   Allen, D ^c   Grant, P ^c   Hyde, S ^c   Laurie, R ^c   Robbie, M ^c   Healy, D ^c   Jobling, T ^c   Manolitsas, T ^c   McNealage, J ^c   Rogers, P ^c   Susil, B ^c   Sumithran, E ^c   Simpson, I ^c   Phillips, K ^c   Rischin, D ^c   Fox, S ^c   Johnson, D ^c   Lade, S ^c   Loughrey, M ^c   O'Callaghan, N ^c   Murray, W ^c   Waring, P ^c   Billson, V ^c   Pyman, J ^c   Neesham, D ^c   Quinn, M ^c   Underhill, C ^c   Bell, R ^c   Ng, L F ^c   Blum, R ^c   Ganju, V ^c   Hammond, I ^c   Leung, Y ^c   McCartney, A ^c   Buck, M ^c   Haviv, I ^c   Purdie, D ^c   Whiteman, D ^c   Zeps, N ^c   Waring, Paul M ^a   Taylor, Graham R ^a   more..

^a UNIVERSITY OF MELBOURNE   (Australia)

^b MURDOCH CHILDREN'S RESEARCH INSTITUTE   (Australia)

^c NONE

Author keywords

[No Author keywords available]

Indexed keywords

AURORA A KINASE; EPIDERMAL GROWTH FACTOR RECEPTOR 2; NEUROFIBROMIN; PHOSPHATIDYLINOSITOL 3,4,5 TRISPHOSPHATE 3 PHOSPHATASE; RETINOBLASTOMA PROTEIN; SCATTER FACTOR RECEPTOR; BRCA1 PROTEIN; BRCA2 PROTEIN; CCNE1 PROTEIN, HUMAN; CYCLIN E; ERBB2 PROTEIN, HUMAN; FORMALDEHYDE; ONCOPROTEIN; PARAFFIN;

AMPLICON; ARTICLE; AURKA GENE; CCNE1 GENE; CONTROLLED STUDY; COPY NUMBER VARIATION; DNA EXTRACTION; EMSY GENE; ERBB2 GENE; FEMALE; GENE; GENE DOSAGE; HIGH THROUGHPUT SEQUENCING; HUMAN; HUMAN TISSUE; LIMIT OF DETECTION; MET GENE; MULTIPLEX LIGATION DEPENDENT PROBE AMPLIFICATION; NF1 GENE; ONCOGENE MYC; OVARY TUMOR; PROCESS DEVELOPMENT; PTEN GENE; QUANTITATIVE ASSAY; RB1 GENE; REPRODUCIBILITY; SENSITIVITY AND SPECIFICITY; TUMOR SUPPRESSOR GENE; CHEMISTRY; GENETICS; METABOLISM; MULTIPLEX POLYMERASE CHAIN REACTION; PROCEDURES; TISSUE FIXATION; TUMOR GENE;

BRCA1 PROTEIN; BRCA2 PROTEIN; CYCLIN E; DNA COPY NUMBER VARIATIONS; FEMALE; FORMALDEHYDE; GENE DOSAGE; GENES, NEOPLASM; HIGH-THROUGHPUT NUCLEOTIDE SEQUENCING; HUMANS; LIMIT OF DETECTION; MULTIPLEX POLYMERASE CHAIN REACTION; ONCOGENE PROTEINS; OVARIAN NEOPLASMS; PARAFFIN EMBEDDING; RECEPTOR, ERBB-2; REPRODUCIBILITY OF RESULTS; SENSITIVITY AND SPECIFICITY; TISSUE FIXATION;

EID: 84957108905     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0143006     Document Type: Article

References (21)

1. Yan M, Parker BA, Schwab R, Kurzrock R. HER2 aberrations in cancer: Implications for therapy. Cancer Treatment Reviews. Elsevier Ltd; 2014 Jul 1; 40(6):770-80.
2. Zhang Y-W. Promise and challenges on the horizon of MET-targeted cancer therapeutics. WJBC. 2015; 6(2):16. doi: 10.4331/wjbc.v6.i2.16 PMID: 26009700
3. Nakayama N, Nakayama K, Shamima Y, Ishikawa M, Katagiri A, Iida K, et al. Gene amplification CCNE1 is related to poor survival and potential therapeutic target in ovarian cancer. Cancer. 2010 Jun 1; 116(11):2621-34. doi: 10.1002/cncr.24987 PMID: 20336784
4. Ledermann J, Harter P, Gourley C, Friedlander M, Vergote I, Rustin G, et al. Olaparib maintenance therapy in patients with platinum-sensitive relapsed serous ovarian cancer: a preplanned retrospective analysis of outcomes by. Lancet Oncology. Elsevier Ltd; 2014 Jun 23; 15(8):852-61.
5. Bruno DL, Stark Z, Amor DJ, Burgess T, Butler K, Corrie S, et al. Extending the scope of diagnostic chromosome analysis: Detection of single gene defects using high-resolution SNP microarrays. Hum Mutat. 2011 Sep 19; 32(12):1500-6. doi: 10.1002/humu.21581 PMID: 21850686
6. Price CM. Fluorescence in situ hybridization. Blood Rev. 1993 Jun; 7(2):127-34. PMID: 8369661
7. D'haene B, Vandesompele J, Hellemans J. Accurate and objective copy number profiling using realtime quantitative PCR. Methods. Elsevier Inc; 2010 Apr 1; 50(4):262-70.
8. Sellner LN, Taylor GR. MLPA and MAPH: New techniques for detection of gene deletions. Hum Mutat. 2004; 23(5):413-9. PMID: 15108271
9. Alsop K, Fereday S, Meldrum C, deFazio A, Emmanuel C, George J, et al. BRCA mutation frequency and patterns of treatment response in BRCA mutation-positive women with ovarian cancer: a report from the Australian Ovarian Cancer Study Group. Journal of Clinical Oncology. 2012 Jul 20; 30(21): 2654-63. doi: 10.1200/JCO.2011.39.8545 PMID: 22711857
10. van Beers EH, Joosse SA, Ligtenberg MJ, Fles R, Hogervorst FBL, Verhoef S, et al. A multiplex PCR predictor for aCGH success of FFPE samples. Br J Cancer. 2005 Dec 6; 94(2):333-7.
11. Bell D, Berchuck A, Birrer M, Chien J, Cramer DW, Dao F, et al. Integrated genomic analyses of ovarian carcinoma. Nature. 2011 Jun 29; 474(7353):609-15. doi: 10.1038/nature10166 PMID: 21720365
12. Kolasa IK, Rembiszewska A, Janiec-Jankowska A, Dansonka-Mieszkowska A, Lewandowska AM, Konopka B, et al. PTEN mutation, expression and LOH at its locus in ovarian carcinomas. Relation to TP53, K-RAS and BRCA1 mutations. Gynecologic Oncology. 2006 Nov; 103(2):692-7. PMID: 16793127
13. Kurman RJ, Shih I-M. Molecular pathogenesis and extraovarian origin of epithelial ovarian cancer - Shifting the paradigm. Human Pathology. 2011 Jul; 42(7):918-31. doi: 10.1016/j.humpath.2011.03.003 PMID: 21683865
14. Gilks CB. Molecular Abnormalities in Ovarian Cancer Subtypes Other than High-Grade Serous Carcinoma. Journal of Oncology. 2010; 2010(10):1-7.
15. Yamamoto S, Tsuda H, Miyai K, Takano M, Tamai S, Matsubara O. Gene amplification and protein overexpression of MET are common events in ovarian clear-cell adenocarcinoma:their roles in tumor progression and prognostication of the patient. Modern Pathology. Nature Publishing Group; 2011 Apr 8; 24(8):1146-55.
16. Mendiola M, Barriuso J, Mariño-Enríquez A, Redondo A, Domínguez-Cáceres A, Hernández-Cortés G, et al. Aurora kinases as prognostic biomarkers in ovarian carcinoma. Human Pathology. 2009 May; 40(5):631-8. doi: 10.1016/j.humpath.2008.10.011 PMID: 19157502
17. Hsu AL, Kondrashova O, Lunke S, Love CJ, Meldrum C, Marquis-Nicholson R, et al. AmpliVar: Mutation Detection in High-Throughput Sequence from Amplicon-Based Libraries. Hum Mutat. 2015 Apr; 36(4):411-8. doi: 10.1002/humu.22763 PMID: 25664426
18. Sluiter MD, van Rensburg EJ. Large genomic rearrangements of the BRCA1 and BRCA2 genes: review of the literature and report of a novel BRCA1 mutation. Breast Cancer Res Treat. 2010 Mar 16; 125(2): 325-49. doi: 10.1007/s10549-010-0817-z PMID: 20232141
19. Szabo C, Masiello A, Ryan JF, Brody LC. The breast cancer information core: database design, structure, and scope. Hum Mutat. 2000; 16(2):123-31. PMID: 10923033
20. Feliubadaló L, Lopez-Doriga A, Castellsagué E, del Valle J, Menéndez M, Tornero E, et al. Nextgeneration sequencing meets genetic diagnostics: development of a comprehensive workflow for the analysis of BRCA1 and BRCA2 genes. Eur J Hum Genet. 2013 Aug; 21(8):864-70. doi: 10.1038/ejhg. 2012.270 PMID: 23249957
21. Berry IR, Delaney CA, Taylor GR. Detecting ligated fragments on oligonucleotide microarrays: optimizing chip design, array multiplex ligation-dependent probe amplification modification, and hybridization parameters. Methods Mol Biol. 2007; 381:247-65. PMID: 17984523